Skip to main content

NUEVOS BIOMARCADORES DEL DESARROLLO TUMORAL: METABOLISMO OXIDATIVO Y RESISTENCIA AL ESTRES

SAF2015-63904-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MiR‐9‐5p protects from kidney fibrosis by metabolic reprogramming

  • Fierro-Fernández, Marta
  • Miguel, Verónica
  • Márquez-Expósito, Laura
  • Nuevo‐Tapioles, Cristina
  • Herrero, José Ignacio
  • Blanco-Ruiz, Eva
  • Tituaña, Jessica
  • Castillo, Carolina
  • Cannata-Ortiz, Pablo
  • Monsalve, María
  • Ruiz-Ortega, Marta
  • Ramos, Ricardo
  • Lamas Peláez, Santiago
MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and control biological processes (BPs), including fibrogenesis. Kidney fibrosis remains a clinical challenge and miRNAs may represent a valid therapeutic avenue. We show that miR‐9‐5p protected from renal fibrosis in the mouse model of unilateral ureteral obstruction (UUO). This was reflected in reduced expression of pro‐fibrotic markers, decreased number of infiltrating monocytes/macrophages, and diminished tubular epithelial cell injury and transforming growth factor‐beta 1 (TGF‐β1)‐dependent de‐differentiation in human kidney proximal tubular (HKC‐8) cells. RNA‐sequencing (RNA‐Seq) studies in the UUO model revealed that treatment with miR‐9‐5p prevented the downregulation of genes related to key metabolic pathways, including mitochondrial function, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and glycolysis. Studies in human tubular epithelial cells demonstrated that miR‐9‐5p impeded TGF‐β1‐induced bioenergetics derangement. The expression of the FAO‐related axis peroxisome proliferator‐activated receptor gamma coactivator 1 alpha (PGC‐1α)‐peroxisome proliferator‐activated receptor alpha (PPARα) was reduced by UUO, although preserved by the administration of miR‐9‐5p. We found that in mice null for the mitochondrial master regulator PGC‐1α, miR‐9‐5p was unable to promote a protective effect in the UUO model. We propose that miR‐9‐5p elicits a protective response to chronic kidney injury and renal fibrosis by inducing reprogramming of the metabolic derangement and mitochondrial dysfunction affecting tubular epithelial cells., This work was supported by Grants from the Ministerio de Economía y Competitividad (MINECO) SAF 2012‐31388 (SL) and SAF2015‐66107‐R (SL), both cofunded by the European Regional Development Fund, Instituto de Salud Carlos III REDinREN RD12/0021/0009 and RD16/0009/0016 (SL and MRO), PI17/00119 (MRO), SAF2015‐63904‐R (MM), cofunded by the European Regional Development Fund, European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement 721236‐TREATMENT (MM), Comunidad de Madrid “NOVELREN” B2017/BMD­3751 (SL and MRO), and Fundación Renal “Iñigo Alvarez de Toledo” (SL), all from Spain. The CBMSO receives institutional support from Fundación “Ramón Areces”. VM and CNT were supported by predoctoral fellowships of the FPI Program (BES‐2013‐065986 and BES‐2014‐068929) from MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pgc1a is responsible for the sex differences in hepatic Cidec/Fsp27 mRNA expression in hepatic steatosis of mice fed a Western diet

  • Herrera-Marcos, Luis V.
  • Sancho-Knapik, Sara
  • Gabás-Rivera, Clara
  • Barranquero, Cristina
  • Gascón, Sonia
  • Romanos, Eduardo
  • Martínez-Beamonte, Roberto
  • Navarro, María A.
  • Surra, Joaquín C.
  • Arnal, Carmen
  • García-de-Jalón, José A.
  • Rodríguez-Yoldi, María Jesús
  • Tena-Sempere, Manuel
  • Sánchez-Ramos, Cristina
  • Monsalve, María
  • Osada, Jesús
Hepatic fat-specific protein 27 [cell death-inducing DNA fragmentation effector protein C (Cidec)/Fsp27] mRNA levels have been associated with hepatic lipid droplet extent under certain circumstances. To address its hepatic expression under different dietary conditions and in both sexes, apolipoprotein E (Apoe)-deficient mice were subjected to different experimental conditions for 11 wk to test the influence of cholesterol, Western diet, squalene, oleanolic acid, sex, and surgical castration on Cidec/Fsp27 mRNA expression. Dietary cholesterol increased hepatic Cidec/Fsp27β expression, an effect that was suppressed when cholesterol was combined with saturated fat as represented by Western diet feeding. Using the latter diet, neither oleanolic acid nor squalene modified its expression. Females showed lower levels of hepatic Cidec/Fsp27β expression than males when they were fed Western diets, a result that was translated into a lesser amount of CIDEC/FSP27 protein in lipid droplets and microsomes. This was also confirmed in low-density lipoprotein receptor (Ldlr)-deficient mice. Incubation with estradiol resulted in decreased Cidec/Fsp27β expression in AML12 cells. Whereas male surgical castration did not modify the expression, ovariectomized females did show increased levels compared with control females. Females also showed increased expression of peroxisome proliferator-activated receptor-γ coactivator 1-α (Pgc1a), suppressed by ovariectomy, and the values were significantly and inversely associated with those of Cidec/Fsp27β. When Pgc1a-deficient mice were used, the sex differences in Cidec/Fsp27β expression disappeared. Therefore, hepatic Cidec/Fsp27β expression has a complex regulation influenced by diet and sex hormonal milieu. The mRNA sex differences are controlled by Pgc1a., This research was supported by Ministerio de Economía y CompetitividadFondo Europeo de Desarrollo Regional (Grants SAF2015-63904-R, SAF2016-75441-R, and RTI2018-093864-B-I00), Fondo Social Europeo-Gobierno de Aragón (Grant B16_17R), and the European Union’s Horizon 2020 research and innovation program under Marie Skłodowska-Curie Grant Agreement 721236-TREATMENT to M. Monsalve. Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CB06/03/1012) is an initiative of Instituto de Salud Carlos III. L. V. Herrera-Marcos and S. Sancho-Knapik were recipients of Fondo Social Europeo-Gobierno de Aragón and Fundación Cuenca-Villoro (BE 203/2009) fellowships, respectively.